Combining internal knowledge and experience with active partnerships, SHL has launched a number of initiatives in the digital space for drug delivery systems.
Menu
SHL Group has announced that it will be holding a webinar discussing…
The rapid growth of biologics and biosimilars has significantly increased the demand for self-injection devices for the treatment of chronic indications.
An article examining SHL’s patient-centric approach to industrial designs was published in the May 2017 issue of OnDrugDelivery Magazine.
The growing demand for treatments using biological drugs has created a challenge for injectable devices to deliver next-generation, high viscosity formulations all the while putting patient comfort and usability first.
SHL will also show the highly-anticipated ENYA Platform, a smart add-on injection tracking offering developed in partnership with Innovation Zed Ltd.
Visit SHL at the Taipei Shangri-La’s Far Eastern Plaza Hotel to learn more about our devices, packaging solutions and innovative offers.
As a forward-looking company with extensive knowledge and experience, SHL delivers solutions for today on the path to tomorrow.
SHL Group is proud to exhibit at Drug Delivery Partnerships in Palm Beach Gardens, Florida on February 7-9, 2017.
